Deuruxolitinib - Concert Pharmaceuticals
At a glance
- Drug Originator Concert Pharmaceuticals
- Drug Licenced by Aclaris Therapeutics
- Drug Class 2 ring heterocyclic compounds; Cyclopentanes; Nitriles; Organic deuterium compounds; Pyrazoles; Pyrimidines; Pyrroles; Skin disorder therapies; Small molecules
- Mechanism of Action Janus kinase 1 inhibitors; Janus kinase 2 inhibitors
- USA Patent Applicants SUN PHARM INDS INC
- USA Patents 3
- NDAs 1
- International Patents 33

Disclaimer